Skip to main content

Table 7 Univariate Analysis for thromboembolic events

From: Thromboembolic events in cancer patients on active treatment with cisplatin-based chemotherapy: another look!

Factors

Number of Patients

Thromboembolic Events 110 (6.6%)

P-value

Age

≤ 60

1276 (76.1%)

81 (6.3%)

0.6445

> 60

401 (23.9%)

29 (7.2%)

Gender

Female

578 (34.5%)

52(9.0%)

0.003

Male

1099 (65.5%)

58 (5.3%)

Khorana risk

High

252 (15.0%)

33 (13.1%)

<0.0001

Others

1423(85.0%)

77 (5.4%)

Central venous catheter

No

1374 (81.9%)

70 (5.1%)

<0.0001

Yes

303 (18.1%)

40 (13.2%)

Primary Tumor

Gastric

191 (11.4%)

40 (20.9%)

<0.0001

Other

1486 (88.6%)

70 (4.7%)

Stage

IV

857 (51.1%)

76 (8.9%)

<0.0001

Early stage

756 (45.1%)

31 (4.1%)